Resultados de la búsqueda 741-750 of 4321 for Spermatogenesis

  1. Oncología (médica) - Ensayos clínicos

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  2. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer.

  3. Oncología (médica) - Ensayos clínicos

    This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and docetaxel ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare the effects (good and bad) on patients with prostate cancer by comparing the standard dose of radiation therapy (44 ...

  5. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to design, develop and assess the performance characteristics of NGS assays using circulating tumor DNA for the ...

  6. Oncología (médica) - Ensayos clínicos

    This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary purpose of the pilot study is to evaluate the safety and tolerability of an autologous dendritic cells (DC) vaccine delivered by intra-tumoral ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the success and effectiveness of gender confirmation surgeries on eliminating gender incongruence and improving life ...

  9. Oncología (médica) - Ensayos clínicos

    This study aims to evaluate the outcomes and patient satisfaction with same day mastectomy with or without alloplastic reconstruction following COVID-19 and ...

  10. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to assess the 36-month incidence of pelvic/non-vaginal recurrence among patients with surgical stage I intermediate-risk ...